{"title":"Using data on the uncertainty of LOAELs to model the probability of observing adverse effects in low-dose studies of the toxicity of chemical mixtures","authors":"Paul Price , Shintaro Hagiwara , Franco Momoli","doi":"10.1016/j.yrtph.2025.105843","DOIUrl":null,"url":null,"abstract":"<div><div>Studies of chemical mixtures toxicity are often designed to differentiate mixtures that follow dose-addition from those that follow response-addition. One design used for this purpose doses animals at levels below the levels that separately have been shown to cause a detectable occurence of a common effect. Under response addition, no effects are expected to be observed since no chemical would independently cause an observable response at the administered doses. Effects, however, could be observed if some or all of the chemicals follow dose addition. Thus, any observation of response can be taken as evidence of dose addition. A recent publication estimated interstudy variation in chemicals’ LOAELs. These estimates are here used to predict the probability of observing an effect in mixtures that follow response- or dose-addition models. Two case studies are presented. One is on a set of hypothetical mixtures containing from 2 to 20 chemicals. The second is on mixtures of anti-androgenic chemicals. In these studies, LOAEL uncertainty blurred the difference between dose and response models, and for many mixtures, it is not possible to determine whether response or dose additivity occurred. These findings suggest that caution should be taken when using these studies as evidence for dose addition.</div></div>","PeriodicalId":20852,"journal":{"name":"Regulatory Toxicology and Pharmacology","volume":"161 ","pages":"Article 105843"},"PeriodicalIF":3.0000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regulatory Toxicology and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S027323002500073X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, LEGAL","Score":null,"Total":0}
引用次数: 0
Abstract
Studies of chemical mixtures toxicity are often designed to differentiate mixtures that follow dose-addition from those that follow response-addition. One design used for this purpose doses animals at levels below the levels that separately have been shown to cause a detectable occurence of a common effect. Under response addition, no effects are expected to be observed since no chemical would independently cause an observable response at the administered doses. Effects, however, could be observed if some or all of the chemicals follow dose addition. Thus, any observation of response can be taken as evidence of dose addition. A recent publication estimated interstudy variation in chemicals’ LOAELs. These estimates are here used to predict the probability of observing an effect in mixtures that follow response- or dose-addition models. Two case studies are presented. One is on a set of hypothetical mixtures containing from 2 to 20 chemicals. The second is on mixtures of anti-androgenic chemicals. In these studies, LOAEL uncertainty blurred the difference between dose and response models, and for many mixtures, it is not possible to determine whether response or dose additivity occurred. These findings suggest that caution should be taken when using these studies as evidence for dose addition.
期刊介绍:
Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.
Types of peer-reviewed articles published:
-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:
1.Factors influencing human sensitivity
2.Exposure science related to risk assessment
3.Alternative toxicological test methods
4.Frameworks for evaluation and integration of data in regulatory evaluations
5.Harmonization across regulatory agencies
6.Read-across methods and evaluations
-Contemporary Reviews on policy related Research issues
-Letters to the Editor
-Guest Editorials (by Invitation)